Tag: Generics

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Sun Pharma obtained FDA approval for its biologics drug

sun pharma
Sun Pharma announced that the U.S. FDA has approved its biologics drug Ilumya (Tildrakizumab) for the treatment of adults with moderate-to-severe plaque psoriasis.

Japan saved $12.2 billion through use of generics

Japan's Ministry of Health, Labour and Welfare (MHLW) suggested that the country's push to lower prescription costs by switching to generic drugs is forecast to have saved $12.2 billion in fiscal 2017.

DSM Sinochem Pharmaceuticals launches Rosuvastatin in Western Europe

DSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries

FAS will support Russian manufacturers in the registration of prices

The head of Federal Antimonopoly Service of Russia Igor Artemyev met with the executives of Pharmstandard PJSC and BIOCAD CJSC

Teva undertakes a restructuring process

Teva Pharmaceutical Industries Ltd. announced a new organization and leadership structure aimed to achieve better commercial focus and drive value creation

Availability of vital and essential drugs in Russia is 65% on average

The number of regions in Russia with the availability of vital and essential drugs below the national average level has increased

A new drug assessment method developed in Russia

Russian scientists proposed a new method for assessing the medicines that will allow to avoid testing drugs in humans

Glenmark entered exclusive agreement with Cyndea Pharma

Glenmark Pharmaceuticals, a global pharmaceutical company, yesterday announced it has entered into a development, license, manufacture and commercial supply agreement with Spanish company Cyndea Pharma S.L.

EC suspects Teva in EU antitrust rules violation

The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust rules

Sandoz obtained EU approval for Rixathon

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that the European Commission (EC) has approved Rixathon

Market share of Russian-made cancer drugs reached 75-80% within three years

The share of Russian-made drugs for treatment and prevention of oncological diseases in the domestic market reached 75-80% in three years

Baxter announced R&D collaboration with Dorizoe Lifesciences

Baxter International Inc., a global medical products company, announced an agreement with Dorizoe Lifesciences Limited

Natco Pharma released generic hepatitis C drug in India

Natco Pharma Limited announced today that it has launched a generic version of Sofosbuvir 400 mg / Velpatasvir 100 mg fixed dose combination in India. Sofosbuvir 400 mg / Velpatasvir 100 mg fixed ...

WHO will attempt to make biosimilar drugs more accessible

This year World Health Organisation (WHO) will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely availab...

Russia approved WTO protocol for the compulsory licensing of pharmaceuticals

drug manufacturing
At a meeting held on April 27, 2017, the Government of the Russian Federation approved the draft federal law "On the Adoption of Protocol Amending the Agreement on Trade-Related Aspects of the Intelle...

Sawai Pharmaceutical buys Upsher-Smith Laboratories

Sawai Pharmaceutical Co. Ltd, a leading Japanese generic pharmaceuticals manufacturer, and Upsher-Smith Laboratories, Inc., an established generics manufacturer based in Minnesota, U.S., today announc...